Latest

Latest clinical trial News | Page 5

  • Latest clinical trial news stories and updates. What is happening today? All recent clinical trial news and developments. Live coverage and timeline of clinical trial. All you need to know about clinical trial.
Major Milestone For UQ Spin-out’s Promising MND Drug
Does menopause hormone therapy increase or decrease your risk of dementia? Here’s the science
Adults grow new brain cells – and these neurons are key to learning by listening
Long-term benefit from anti-hormonal treatment is influenced by menopausal status
Parkinson’s researchers call for people who act out their dreams for world-first trial
Precision Medicine Transforming Treatment For Corneal Blindness
Long COVID appears to be driven by ‘long infection’. Here’s what the science says
Researchers discover new treatment for rare immune disease
Galderma’s Phase III OLYMPIA 1 Data Published in JAMA Dermatology Demonstrate That Nemolizumab Improves Core Signs and Symptoms of Prurigo Nodularis
QIMR Berghofer depression discovery brings fresh hope for ‘melancholia’
Largest-ever global study of bloodstream infection reveals long courses of antibiotics in hospital may not be required
RNA editing is the next frontier in gene therapy – here’s what you need to know
Lake Macquarie Private Hospital becomes first Australian site to join new breast cancer trial
Neurizon Therapeutics says candidate reduces aggregation of key ALS disease target
Monash-led research is expanding treatment options for high cholesterol
Promising daily tablet increases growth in children with dwarfism
HistoSonics® Enrolls First Patients in Company’s Novel BOOMBOX Master Study
Funding Gift For Spinal Injury Clinical Trial
Medidata Secures Highest Leadership Position in Everest Group’s First Life Sciences Clinical Trial Management System Products PEAK Matrix® Assessment
MEB Receives 86 Millions In Swedish Grants
National Anti-vaping Program For Young Australians
‘Sleepy cannabis’: first objective study to show cannabinol increases sleep
Recce says patient dosing in Phase 2 clinical trial advances to final stages
Suffering from recurrent UTIs? Join clinical trial testing natural preventative
Ryan’s “I Was Told I Would Be Dead By Christmas”
Alzheimer’s treatment donanemab is not a ‘miracle drug’ – not providing it on the NHS is the right choice
Medidata Launches Bundled Solutions to Support Oncology and Vaccine Trials, Accelerating Study Design and Execution
First Site Initiated in Australia for MannKind’s Phase 3 Clinical Trial Evaluating Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease
New algorithm picks fairer shortlist when applicants abound
Polycystic ovary syndrome needs better management: study
What is stereotactic radiation therapy for prostate cancer? How does it compare to other treatments?
Seaport Therapeutics secures US$225 Series B funding to develop neuropsychiatric medicines using Monash University prodrug technology
Athos Announces Positive Topline Phase 1 Data for its AI-Generated, Novel, Oral G9A Inhibitor ATH-063, Demonstrating Selective Expansion and Activation of Potent…
Mater Launches Trial Of Combined COVID-flu Vaccine
Combining two common medications may pave the way for a new dementia treatment
Chimeric says cancer patient achieves complete response in CHM CORE-NK trial
Hoarding disorder: ‘sensory CBT’ treatment strategy shows promise
Drug Trial Studies Oral Cancer Therapy For Dogs
GE HealthCare Announces Phase I Results for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent
Hoarding disorder: ‘sensory CBT’ treatment strategy shows promise
New drug could be answer to an overlooked yet devastating type of dementia
Curium Announces Strategic Partnership with PeptiDream for Prostate Cancer Theranostics in Japan
Nanoscope Therapeutics Licenses Optogenetic Technology
Primary Endpoint Met in Phase 3 Comparative Clinical Study of Perjeta® (pertuzumab) Biosimilar Candidate HLX11
Logan Hospital LEADS Awarded Centre Of Excellence
Chimeric announces new collaboration with Achieve Clinics
PCI Pharma Services Invests Over $365 Million in EU, US Facilities for Clinical and Commercial Supply of Advanced Drug Delivery and Drug-Device Combination Products
ITM Obtains Exclusive Worldwide License from Debiopharm for CA IX-Targeted Peptide-based Radiopharmaceutical Programs Targeting Solid Tumors

© 2026 - The National Tribune Australia